Cargando…
Autoimmune liver disease-related autoantibodies in patients with biliary atresia
AIM: To investigate the prevalence and clinical significance of autoimmune liver disease (ALD)-related autoantibodies in patients with biliary atresia (BA). METHODS: Sera of 124 BA patients and 140 age-matched non-BA controls were assayed for detection of the following autoantibodies: ALD profile an...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776400/ https://www.ncbi.nlm.nih.gov/pubmed/29391761 http://dx.doi.org/10.3748/wjg.v24.i3.387 |
_version_ | 1783294077228285952 |
---|---|
author | Pang, Shu-Yin Dai, Yu-Mei Zhang, Rui-Zhong Chen, Yi-Hao Peng, Xiao-Fang Fu, Jie Chen, Zheng-Rong Liu, Yun-Feng Yang, Li-Yuan Wen, Zhe Yu, Jia-Kang Liu, Hai-Ying |
author_facet | Pang, Shu-Yin Dai, Yu-Mei Zhang, Rui-Zhong Chen, Yi-Hao Peng, Xiao-Fang Fu, Jie Chen, Zheng-Rong Liu, Yun-Feng Yang, Li-Yuan Wen, Zhe Yu, Jia-Kang Liu, Hai-Ying |
author_sort | Pang, Shu-Yin |
collection | PubMed |
description | AIM: To investigate the prevalence and clinical significance of autoimmune liver disease (ALD)-related autoantibodies in patients with biliary atresia (BA). METHODS: Sera of 124 BA patients and 140 age-matched non-BA controls were assayed for detection of the following autoantibodies: ALD profile and specific anti-nuclear antibodies (ANAs), by line-blot assay; ANA and anti-neutrophil cytoplasmic antibody (ANCA), by indirect immunofluorescence assay; specific ANCAs and anti-M2-3E, by enzyme linked immunosorbent assay. Associations of these autoantibodies with the clinical features of BA (i.e., cytomegalovirus infection, degree of liver fibrosis, and short-term prognosis of Kasai procedure) were evaluated by Spearman’s correlation coefficient. RESULTS: The overall positive rate of serum autoantibodies in preoperative BA patients was 56.5%. ALD profile assay showed that the positive reaction to primary biliary cholangitis-related autoantibodies in BA patients was higher than that to autoimmune hepatitis-related autoantibodies. Among these autoantibodies, anti-BPO was detected more frequently in the BA patients than in the controls (14.8% vs 2.2%, P < 0.05). Accordingly, 32 (25.8%) of the 124 BA patients also showed a high positive reaction for anti-M2-3E. By comparison, the controls had a remarkably lower frequency of anti-M2-3E (P < 0.05), with 6/92 (8.6%) of patients with other liver diseases and 2/48 (4.2%) of healthy controls. The prevalence of ANA in BA patients was 11.3%, which was higher than that in disease controls (3.3%, P < 0.05), but the reactivity to specific ANAs was only 8.2%. The prevalence of ANCAs (ANCA or specific ANCAs) in BA patients was also remarkably higher than that in the healthy controls (37.9% vs 6.3%, P < 0.05), but showed no difference from that in patients with other cholestasis. ANCA positivity was closely associated with the occurrence of postoperative cholangitis (r = 0.61, P < 0.05), whereas none of the autoantibodies showed a correlation to cytomegalovirus infection or the stages of liver fibrosis. CONCLUSION: High prevalence of autoantibodies in the BA developmental process strongly reveals the autoimmune-mediated pathogenesis. Serological ANCA positivity may be a useful predictive biomarker of postoperative cholangitis. |
format | Online Article Text |
id | pubmed-5776400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-57764002018-02-01 Autoimmune liver disease-related autoantibodies in patients with biliary atresia Pang, Shu-Yin Dai, Yu-Mei Zhang, Rui-Zhong Chen, Yi-Hao Peng, Xiao-Fang Fu, Jie Chen, Zheng-Rong Liu, Yun-Feng Yang, Li-Yuan Wen, Zhe Yu, Jia-Kang Liu, Hai-Ying World J Gastroenterol Retrospective Study AIM: To investigate the prevalence and clinical significance of autoimmune liver disease (ALD)-related autoantibodies in patients with biliary atresia (BA). METHODS: Sera of 124 BA patients and 140 age-matched non-BA controls were assayed for detection of the following autoantibodies: ALD profile and specific anti-nuclear antibodies (ANAs), by line-blot assay; ANA and anti-neutrophil cytoplasmic antibody (ANCA), by indirect immunofluorescence assay; specific ANCAs and anti-M2-3E, by enzyme linked immunosorbent assay. Associations of these autoantibodies with the clinical features of BA (i.e., cytomegalovirus infection, degree of liver fibrosis, and short-term prognosis of Kasai procedure) were evaluated by Spearman’s correlation coefficient. RESULTS: The overall positive rate of serum autoantibodies in preoperative BA patients was 56.5%. ALD profile assay showed that the positive reaction to primary biliary cholangitis-related autoantibodies in BA patients was higher than that to autoimmune hepatitis-related autoantibodies. Among these autoantibodies, anti-BPO was detected more frequently in the BA patients than in the controls (14.8% vs 2.2%, P < 0.05). Accordingly, 32 (25.8%) of the 124 BA patients also showed a high positive reaction for anti-M2-3E. By comparison, the controls had a remarkably lower frequency of anti-M2-3E (P < 0.05), with 6/92 (8.6%) of patients with other liver diseases and 2/48 (4.2%) of healthy controls. The prevalence of ANA in BA patients was 11.3%, which was higher than that in disease controls (3.3%, P < 0.05), but the reactivity to specific ANAs was only 8.2%. The prevalence of ANCAs (ANCA or specific ANCAs) in BA patients was also remarkably higher than that in the healthy controls (37.9% vs 6.3%, P < 0.05), but showed no difference from that in patients with other cholestasis. ANCA positivity was closely associated with the occurrence of postoperative cholangitis (r = 0.61, P < 0.05), whereas none of the autoantibodies showed a correlation to cytomegalovirus infection or the stages of liver fibrosis. CONCLUSION: High prevalence of autoantibodies in the BA developmental process strongly reveals the autoimmune-mediated pathogenesis. Serological ANCA positivity may be a useful predictive biomarker of postoperative cholangitis. Baishideng Publishing Group Inc 2018-01-21 2018-01-21 /pmc/articles/PMC5776400/ /pubmed/29391761 http://dx.doi.org/10.3748/wjg.v24.i3.387 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Pang, Shu-Yin Dai, Yu-Mei Zhang, Rui-Zhong Chen, Yi-Hao Peng, Xiao-Fang Fu, Jie Chen, Zheng-Rong Liu, Yun-Feng Yang, Li-Yuan Wen, Zhe Yu, Jia-Kang Liu, Hai-Ying Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title | Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title_full | Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title_fullStr | Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title_full_unstemmed | Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title_short | Autoimmune liver disease-related autoantibodies in patients with biliary atresia |
title_sort | autoimmune liver disease-related autoantibodies in patients with biliary atresia |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776400/ https://www.ncbi.nlm.nih.gov/pubmed/29391761 http://dx.doi.org/10.3748/wjg.v24.i3.387 |
work_keys_str_mv | AT pangshuyin autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT daiyumei autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT zhangruizhong autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT chenyihao autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT pengxiaofang autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT fujie autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT chenzhengrong autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT liuyunfeng autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT yangliyuan autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT wenzhe autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT yujiakang autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia AT liuhaiying autoimmuneliverdiseaserelatedautoantibodiesinpatientswithbiliaryatresia |